55
Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor Director of Neurocritical Care UCLA Brain Injury Research Center

Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Positron Emission Tomography Imaging in Brain

Injured Patients

Paul Vespa, MD Professor

Director of Neurocritical Care UCLA Brain Injury Research Center

Page 2: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Outline

• Clinical Context of imaging • Practical issues • Major Hypotheses/Questions being

addressed – Ischemia – Metabolic crisis – Chronic traumatic encephalopathy – Prognosis

Page 3: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

ICU Environment

Page 4: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Human PET Center

Page 5: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical
Page 6: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Limitations to human experimentation

• Timing of studies is dependent on patient stability

• Radiation dosing is limited • Missing data points require special

statistics

Page 7: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Basic Design • Structural imaging with CT and MRI • PET image with an available clinical PET

ligand – Dynamic quantitative image for regional

assessment – FDG – O2 – F18- MISO – FDDNP – C-PIB

Page 8: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

TBI results in metabolic disturbance

• Cascade of metabolic events after TBI

• Initial depolarization event most important

Katayama et al 1990

Page 9: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Disturbed metabolism after TBI

• Reduced CBF related to decreased demand, impaired microcirculation (low NO), and iatrogenic causes (HV, CPP)

• Decreased rate of CMRO2 related to mitochondrial dysfunction

• Increase glucose utilization CBF

FDG

Page 10: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Time course of TBI • Early hypotension and brain ischemia

within the initial 12 hours • Mass effect that requires surgery • ICP related to brain edema • Periodic insults due to seizures

– Possibly brain ischemia events • 7-10 days of disturbed brain

hemodynamics and altered brain metabolism in the ICU

Page 11: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Classical Ischemia

Increased OEF =0.79

Reduced CBF = 20

Reduced CMRO2 =1.2

Page 12: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Classical Ischemia

Page 13: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Oxidative metabolism is reduced to a critical threshold

• Menon et al 2004 • Large regions of the brain have critically low

rates of CMRO2 • Regions of not directly adjacent to contusions

Page 14: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Coles, Menon et al J Cereb Blood Flow Metab 2004

Page 15: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Hyperventilation not inducing ischemia – Diringer et al 2005

Page 16: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Absence of brain ischemia adjacent to a contusion OEF = 0.25

CBF = 49.6 cc/100gm/min

Page 17: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Asymmetric OEF with right side higher

PET O15 OEF = .50 in red crescent

Page 18: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Goals of treatment

• The goal is to maintain adequate perfusion with cerebral blood flow that is sufficient to supply the increased energy demand

• PET can provide evidence of response in CBF to changes in blood pressure or supplemental fluids or blood

Page 19: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

•6 patients with SAH vasospasm •O-15 SBF PET before and after fluid challenge • 1 L Normal Saline fluid challenge

Jost, Diringer et al 2005

Page 20: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

J Neurosurgery, 116, March 2012

Page 21: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Reversing ischemia through hyperoxia

• Increase in CMRO2 in tissue at risk by delivery of normobaric hyperoxia (but not for whole brain)

• Reduction in LPR 34.1 to 32.5 (P < 0.035)

Nortje, Menon et al 2008

Page 22: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

PET and Microdialysis after SAH Sarrafzadeh and Unterberg , 2004

Page 23: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

PET with SAH cerebral Ischemia using F18-MISO

Saffarzadeh, Unterberg et al 2010

Page 24: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

F18- MISO in SAH

Page 25: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical
Page 26: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Non-ischemic Metabolic Crisis

Page 27: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

N = 28 TBI Hyperglycolysis in 12/28 Early after TBI day < 5

Page 28: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Hyperglycolysis after TBI

Page 29: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Regional Hyperglycolysis

Page 30: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Seizures associated with hyperglycolysis

Page 31: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

CMRglc 2.9-3.2

CBF 21-24

CBF 16

Microdialysis: Glucose 2.0 Lactate 0.8 Glutamate 1.6 Glycerol 44 L/P 56

CBF 37

PET in TBI showing regional metabolic crisis and low CBF

Page 32: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Elevated LPR without ischemia LPR = 100 during PET

LPR ratio

020406080

100120140160

59 60 61 62 63 64 65

PIH

Lact

ate/

pyru

vate

Vespa et al J Cereb Blood Flow Metab 2005

Page 33: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

0102030405060708090

100

11 13 15 17 19 21 23 25 27 29 31 33

ICPSJVO2CPP

PI hour

Post TBI seizures lead to additional disturbance of metabolism without ischemia

EEG

CT

ICP, SJVO2 and CPP

Vespa et al Neurology 2010

Page 34: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Brin(green)Glycerol

0

10

20

30

40

50

75 85 95 105 115 125 135 145 155

Post-Injury Hrs

ICP

0.00

5.00

10.00

15.00

20.00

72 82 92 102 112 122 132 142 152 162

PIH

mm

Hg

SjvO2

0.00

20.00

40.00

60.00

80.00

100.00

72 82 92 102 112 122 132 142 152 162

PIH

% s

at

seizures

Increased glycolysis

Initial CT Post-op

MD glycerol increased

Post-traumatic seizures elicit increased glycolysis

Page 35: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Use of PET to determine optimal glucose delivery

Glucose = 77 Glucose = 127

Vespa et al Crit Care Medicine (in press for 2012)

Page 36: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Increase in hyperglycolysis under conditions of tight glycemic control

• Regional variation of baseline glucose metabolism

• Increased glucose metabolism when serum glucose is restricted

• Similar changes in white and grey matter • Least change in pericontusional tissue • MD glucose decreased and glycerol higher

under tight glycemic control

Vespa et al Crit Care Med 2012

Page 37: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Progressive Disease and Prognosis

• TBI and other acute neurocritical care illnesses are disease processes, not just acute injuries

• PET can be used to study the prognosis of the chronic disease and to investigate possible disease mechanisms – Programmed cell death – Tau and Amyloid deposition

Page 38: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical
Page 39: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Chronic Atrophy at 6 months

Page 40: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Primary acute injury is hemorrhagic, not ischemic

Page 41: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Metabolic Rates acutely after TBI

Page 42: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Chronic atrophy

Page 43: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

CMRO2

CBF

CMRglucose Frontal lobe

Frontal Temporal Parietal

Page 44: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Long term atrophy

Acute Chronic at 6 months

Page 45: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical
Page 46: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Brain Atrophy after NCSE in TBI

Page 47: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Hippocampal atrophy after post-traumatic seizures

Acute FLAIR MRISubdural Hemorrhage

Acute ADC MRIHippocampus = 1001 u2/s

Chronic MRIHippocampal Atrophy

Status Epilepticuson post injury day 5

Page 48: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Increased hippocampal atrophy in patients with post-traumatic seizures

Vespa et al Neurology 2010

Page 49: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Impaired long term cognition and cortical atrophy after metabolic crisis

Wright et al 2013 Dinov et al (in press)

Page 50: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

FDG in Mild TBI – relation to memory disorder

Page 51: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Z scores showing differences in FDG in various regions

Page 52: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Chronic tau deposition in long term CTE in NFL players - Small et al 2013

Page 53: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

FDDNP in NFL Small et al 2013

Page 54: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

N = 12 military blast injury N = 12 blunt TBI Resting state FDG PET - semi quantitative Comparison of ROI vs Normals

Page 55: Positron Emission Tomography Imaging in Brain Injured Patients · Positron Emission Tomography Imaging in Brain Injured Patients Paul Vespa, MD Professor . Director of Neurocritical

Summary of imaging in acute brain injury